ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
127.411,55
-0,27%
S&P 500
5.321,41
0,25%
US Dollar vs BRL
5,1175
0,25%
Bitcoin
69.675,95
-2,48%
Brent Oil
82,695
-1,00%
Registration Strip Icon for default Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Mind Medicine MindMed Inc (MNMD)

  7. Mind Medicine MindMed Inc (MNMD) Notícias

MNMD

Mind Medicine MindMed (MNMD)

Mind Medicine MindMed Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:MNMD
DataHoraFonteTítuloCódigoCompanhia
09/05/202417:01Business WireMindMed to Participate at May Investor ConferencesNASDAQ:MNMDMind Medicine MindMed Inc
09/05/202409:00Business WireNew Studies Presented at the International Society for Health Economics and Outcomes Research Meeting (ISPOR 24) Show Growing Burden and Impact of Generalized Anxiety Disorder (GAD) in the USNASDAQ:MNMDMind Medicine MindMed Inc
08/05/202417:15Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:MNMDMind Medicine MindMed Inc
08/05/202417:10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MNMDMind Medicine MindMed Inc
08/05/202417:01Business WireMindMed Reports First Quarter 2024 Financial Results and Business UpdatesNASDAQ:MNMDMind Medicine MindMed Inc
04/05/202409:00Business WireMindMed Presents Phase 2b Study of MM120 for Generalized Anxiety Disorder (GAD) at American Psychiatric Association (APA) Annual Meeting in New YorkNASDAQ:MNMDMind Medicine MindMed Inc
02/05/202408:00Business WireMindMed to Host Conference Call and Webcast to Discuss First Quarter 2024 Financial Results and Provide Business UpdateNASDAQ:MNMDMind Medicine MindMed Inc
25/04/202408:00Business WireMindMed to Present at Upcoming May Medical ConferencesNASDAQ:MNMDMind Medicine MindMed Inc
02/04/202408:00Business WireMindMed to Present at Upcoming April Medical ConferencesNASDAQ:MNMDMind Medicine MindMed Inc
01/04/202418:00Business WireMindMed Announces Voluntary Delisting from Cboe CanadaNASDAQ:MNMDMind Medicine MindMed Inc
11/03/202408:00Business WireMindMed to Participate in the Leerink Partners 2024 Global Biopharma ConferenceNASDAQ:MNMDMind Medicine MindMed Inc
07/03/202409:13Business WireMind Medicine (MindMed) Inc. Announces Pricing of Underwritten Offering of Common Shares and Concurrent Private PlacementNASDAQ:MNMDMind Medicine MindMed Inc
07/03/202409:09Edgar (US Regulatory)Form S-3MEF - Registration adding securities to prior Form S-3 registration [Rule 462(b)]NASDAQ:MNMDMind Medicine MindMed Inc
07/03/202408:00Business WireMindMed Receives FDA Breakthrough Therapy Designation and Announces Positive 12-Week Durability Data From Phase 2B Study of MM120 for Generalized Anxiety DisorderNASDAQ:MNMDMind Medicine MindMed Inc
01/03/202415:56Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:MNMDMind Medicine MindMed Inc
01/03/202411:00Business WireMindMed to Host Conference Call and Webcast to Discuss Data Update for MM120NASDAQ:MNMDMind Medicine MindMed Inc
29/02/202418:45Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MNMDMind Medicine MindMed Inc
28/02/202409:20Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:MNMDMind Medicine MindMed Inc
28/02/202409:05Business WireMindMed Reports 2023 Financial Results and Business UpdatesNASDAQ:MNMDMind Medicine MindMed Inc
22/02/202409:00Business WireMindMed to Host Conference Call and Webcast to Discuss 2023 Financial Results and Provide Business UpdateNASDAQ:MNMDMind Medicine MindMed Inc
07/02/202409:00Business WireMindMed to Participate in the 34th Annual Oppenheimer Healthcare Life Sciences ConferenceNASDAQ:MNMDMind Medicine MindMed Inc
08/01/202409:45Business WireMindMed Announces Business Update and Anticipated Milestones for 2024NASDAQ:MNMDMind Medicine MindMed Inc
14/12/202309:30Business WireMindMed Announces Positive Topline Results from Phase 2b Trial of MM-120 in Generalized Anxiety DisorderNASDAQ:MNMDMind Medicine MindMed Inc
02/11/202317:01Business WireMindMed Reports Third Quarter 2023 Financial Results and Business HighlightsNASDAQ:MNMDMind Medicine MindMed Inc
26/10/202308:30Business WireMindMed to Host Conference Call and Webcast to Discuss Third Quarter 2023 Financial Results and Provide Business UpdateNASDAQ:MNMDMind Medicine MindMed Inc
24/10/202308:30Business WireMindMed Completes Enrollment of Phase 2a Trial of MM-120 in Adults with Attention-Deficit/Hyperactivity Disorder (ADHD)NASDAQ:MNMDMind Medicine MindMed Inc
03/10/202308:30Business WireMindMed to Present Data on the Preclinical Activity of MM-402 at the 36th Annual European College of Neuropsychopharmacology (ECNP) CongressNASDAQ:MNMDMind Medicine MindMed Inc
15/09/202318:27Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:MNMDMind Medicine MindMed Inc
14/09/202308:30Business WireMindMed to Participate in the TD Cowen 3rd Annual Novel Mechanisms in Neuropsychiatry SummitNASDAQ:MNMDMind Medicine MindMed Inc
12/09/202308:30Business WireMindMed Completes Enrollment of Phase 2b Trial of MM-120 in Generalized Anxiety Disorder (GAD)NASDAQ:MNMDMind Medicine MindMed Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:MNMD

Seu Histórico Recente

BOV
IBOV
Índice Bovespa
BOV
PDGR3
PDG REALT ON
BOV
HAGA3
HAGA ON
BOV
PRIO3
PETRORIO ON
BOV
COGN3
COGNA ON
BOV
SGPS3
SPRINGS ON
BOV
MGLU3
MAGAZINE LUIZA ON
BOV
BHIA3
Grupo Casas Bahia ON
BOV
INBR32
Inter &
BOV
LUPA3
LUPATECH ON
BOV
IFCM3
Infracommerce Caxaas ON
BOV
GFSA3
GAFISA ON
BOV
HBOR3
HELBOR ON
BOV
JHSF3
JHSF PART ON
BOV
AZEV4
AZEVEDO PN
BOV
HOOT4
HOTEIS OTHON PN
Delayed Upgrade Clock
ADVFN Logo

Brasil
Empresa
Negócios
Popular
Obter o aplicativo

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados